Anti‐SARS‐CoV‐2 effect of extracellular vesicles released from mesenchymal stem cells-Reference-Cited by-同舟云学术

Anti‐SARS‐CoV‐2 effect of extracellular vesicles released from mesenchymal stem cells

Published:2022-03 Issue:3 Volume:11 Page:
ISSN:2001-3078
Container-title:Journal of Extracellular Vesicles
language:en
Short-container-title:J of Extracellular Vesicle

Author:

Chutipongtanate Somchai¹²³⁴^ORCID,Kongsomros Supasek¹⁵,Pongsakul Nutkridta¹,Panachan Jirawan⁶,Khowawisetsut Ladawan⁷,Pattanapanyasat Kovit⁸,Hongeng Suradej⁶,Thitithanyanont Arunee⁵

Affiliation:

1. Pediatric Translational Research Unit Department of Pediatrics Faculty of Medicine Ramathibodi Hospital Mahidol University Bangkok Thailand

2. Department of Clinical Epidemiology and Biostatistics Faculty of Medicine Ramathibodi Hospital Mahidol University Bangkok Thailand

3. Chakri Naruebodindra Medical Institute Faculty of Medicine Ramathibodi Hospital Mahidol University Samut Prakan Thailand

4. Division of Epidemiology, Department of Environmental and Public Health Sciences University of Cincinnati College of Medicine Cincinnati OH 45267 USA

5. Department of Microbiology Faculty of Science Mahidol University Bangkok Thailand

6. Division of Hematology and Oncology Department of Pediatrics Faculty of Medicine Ramathibodi Hospital Mahidol University Bangkok Thailand

7. Department of Parasitology Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand

8. Center of Excellence for Microparticle and Exosome in Diseases Research Department Faculty of Medicine Siriraj Hospital Mahidol University Bangkok Thailand

Publisher

Wiley

Subject

Cell Biology,Histology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jev2.12201

Reference21 articles.

1. COVID‐19 therapy with mesenchymal stromal cells (MSC) and convalescent plasma must consider exosome involvement: Do the exosomes in convalescent plasma antagonize the weak immune antibodies?

2. Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection

3. Human Colostrum and Derived Extracellular Vesicles Prevent Infection by Human Rotavirus and Respiratory Syncytial Virus in Vitro

4. Mesenchymal Stem Cell-Derived Exosomes: Applications in Regenerative Medicine

5. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual Role of Extracellular Vesicles as Orchestrators of Emerging and Reemerging Virus Infections;Cell Biochemistry and Biophysics;2024-09-03

2. Therapeutic potential of mesenchymal stem cell‐derived extracellular vesicles in SARS‐CoV‐2 and H1N1 influenza‐induced acute lung injury;Journal of Extracellular Vesicles;2024-09

3. Flow cytometry for extracellular vesicle characterization in COVID-19 and post-acute sequelae of SARS-CoV-2 infection;Extracellular Vesicles and Circulating Nucleic Acids;2024-08-09

4. Development of red blood cell-derived extracellular particles as a biocompatible nanocarrier of microRNA-204 (REP-204) to harness anti-neuroblastoma effect;Nanomedicine: Nanotechnology, Biology and Medicine;2024-08

5. Comprehensive proteomic analysis of HCoV-OC43 virions and virus-modulated extracellular vesicles;Journal of Virology;2024-07-23